National Center for Research Resources; Notice of Closed Meeting, 16797-16798 [2011-7137]
Download as PDF
<![CDATA[
Federal Register / Vol. 76, No. 58 / Friday, March 25, 2011 / Notices
erowe on DSK5CLS3C1PROD with NOTICES
steering committees and working groups
to ensure appropriate project
implementation, oversight, and
management for all projects under the
PPP.
• Development of a scientific review
panel to evaluate the progress of
projects funded under the PPP and
development of feasibility plans for
additional projects aligned with PASI.
• Coordination with FDA and other
partners; the development and
publication of scientific articles in
support of educational and outreach
activities (with data, know-how, and
other outcomes from the
aforementioned projects supported
under the PPP) and to benefit patients
and other stakeholders.
• Development of a strategy to
identify and establish relationships with
key experts in the fields of anesthesia
and sedation, including stakeholders
from industry, professional
organizations, academia, and awardees
of the projects under the ‘‘research and
analysis’’ section for leveraging and
collaborative efforts under PASI.
• Coordination of annual scientific
workshops with collaboration by FDA
and the aforementioned experts in the
fields of anesthesia and sedation,
including stakeholders from industry,
professional organizations, academia,
and Government Agencies.
2. Research projects (which may
include, but are not limited to):
• Clinical trials including
prospective, randomized, and blinded
investigations assessing the immediate
and delayed neurodevelopmental effects
of regional/caudal anesthesia versus
general anesthesia in neonates/infants;
• Observational trials including the
comparison of two groups of children,
one group exposed to general anesthesia
within the first 3 years of life and the
other, unexposed. Assessments should
utilize neuropsychological tests of
attention, memory, motor function, and
behavior; and
• Epidemiologic investigations
surveying large existing population
databases for cognitive developmental
effects where exposure to general
anesthesia before the age of 3 can be
compared to the overall population.
C. Eligibility Information
Higher education institutions:
• Public/state-controlled institutions
of higher education
• Private institutions of higher
education
The following types of higher
education institutions are always
encouraged to apply for National
Institutes of Health support as public or
private institutions of higher education:
VerDate Mar<15>2010
15:16 Mar 24, 2011
Jkt 223001
• Hispanic serving institutions
• Historically Black colleges and
universities
• Tribally controlled colleges and
universities
• Alaska Native and Native Hawaiian
serving institutions
Nonprofits other than institutions of
higher education
• Nonprofits with 501(c)(3) Internal
Revenue Service (IRS) status (other than
institutions of higher education)
• Nonprofits without 501(c)(3) IRS
status (other than institutions of higher
education)
For-profit organizations:
• Small businesses
• For-profit organizations (other than
small businesses)
Other:
• Regional organizations
Non-domestic (non-U.S.) entities
(foreign organizations) are not eligible to
apply. Foreign (non-U.S.) components
of U.S. organizations are not allowed.
II. Award Information/Funds Available
16797
• Step 1: Obtain a Dun and Bradstreet
(DUNS) Number
• Step 2: Register With Central
Contractor Registration
• Step 3: Obtain Username and
Password
• Step 4: Authorized Organization
Representative (AOR) Authorization
• Step 5: Track AOR Status
• Step 6: Register With Electronic
Research Administration (eRA)
Commons Steps 1 through 5, in detail,
can be found at https://
www07.grants.gov/applicants/
organization_registration.jsp. Step 6, in
detail, can be found at https://
commons.era.nih.gov/commons/
registration/registrationInstructions.jsp.
After you have followed these steps,
submit electronic applications to:
https://www.grants.gov/.
Dated: March 21, 2011.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2011–7055 Filed 3–24–11; 8:45 am]
BILLING CODE 4160–01–P
A. Award Amount
FDA intends to fund one or more
awards, corresponding to a total of $1
million, for fiscal year 2011, to carry out
the project management and research
project objectives described in Part I of
this document. Future year amounts
will depend on annual appropriations.
No more than four awards are
anticipated under this FOA. The
number of awards is contingent upon
FDA appropriations and the submission
of a sufficient number of meritorious
applications.
B. Length of Support
The anticipated length of the
individual awards is 5 years.
III. Electronic Application,
Registration, and Submission
Only electronic applications will be
accepted. To submit an electronic
application in response to this FOA,
applicants should first review the full
announcement located at https://
grants.nih.gov/grants/guide/ (select the
‘‘Request for Applications’’ link),
https://www.grants.gov/ (see ‘‘For
Applicants’’ section) and https://
www.fda.gov/AboutFDA/
PartnershipsCollaborations/
PublicPrivatePartnershipProgram/
ucm166082.htm. (FDA has verified the
Web site addresses throughout this
document, but FDA is not responsible
for any subsequent changes to the Web
sites after this document publishes in
the Federal Register.) For all
electronically submitted applications,
the following steps are required:
PO 00000
Frm 00074
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center for Research
Resources; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Center for
Research Resources Special Emphasis Panel;
LOAN REPAYMENT.
Date: April 7, 2011.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Carol Lambert, PhD,
Scientific Review Officer, Office of Review,
NCRR, National Institutes of Health, 6701
Democracy Blvd., One Democracy Plaza,
Room 1076, MSC 4874, Bethesda, MD 20892–
4874, 301–435–0814, lambert@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
E:\FR\FM\25MRN1.SGM
25MRN1
16798
Federal Register / Vol. 76, No. 58 / Friday, March 25, 2011 / Notices
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research; 93.371, Biomedical
Technology; 93.389, Research Infrastructure,
93.306, 93.333; 93.702, ARRA Related
Construction Awards., National Institutes of
Health, HHS)
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: March 21, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 USC,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable materials,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
[FR Doc. 2011–7137 Filed 3–24–11; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
erowe on DSK5CLS3C1PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Host Response to
Francisella.
Date: May 11, 2011.
Time: 1 p.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6700B
Rockledge Drive, Bethesda, MD 20817,
(Telephone Conference Call)
Contact Person: Lynn Rust, PhD, Scientific
Review Officer,Scientific Review Program,
Division of Extramural Activities, NIAID/
NIH/DHHS, 6700B Rockledge Drive, MSC
7616, Bethesda, MD 20892, (301) 402–3938,
lr228v@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: March 21, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2011–7136 Filed 3–24–11; 8:45 am]
BILLING CODE 4140–01–P
VerDate Mar<15>2010
15:16 Mar 24, 2011
Jkt 223001
National Institutes of Health
National Institute on Alcohol Abuse
and Alcoholism; Notice of Closed
Meeting
Name of Committee: National Institute on
Alcohol Abuse and Alcoholism Initial
Review Group; Neuroscience Review
Subcommittee.
Date: June 9–10, 2011.
Time: 8:30 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20852.
Contact Person: Beata Buzas, PhD,
Scientific Review Officer, National Institute
on Alcohol Abuse and Alcoholism, National
Institutes of Health, 5635 Fishers Lane, Room
2081, Rockville, MD 20852, 301–443–0800,
bbuzas@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.271, Alcohol Research
Career Development Awards for Scientists
and Clinicians; 93.272, Alcohol National
Research Service Awards for Research
Training; 93.273, Alcohol Research Programs;
93.891, Alcohol Research Center Grants;
93.701, ARRA Related Biomedical Research
and Research Support Awards., National
Institutes of Health, HHS)
Dated: March 18, 2011.
Jennifer Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2011–7134 Filed 3–24–11; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Mechanisms
of Neurodegeneration.
Date: April 18, 2011.
Time: 11 a.m. to 1 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Toby Behar, PhD,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4136,
MSC 7850, Bethesda, MD 20892, (301) 435–
4433, behart@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: March 21, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2011–7133 Filed 3–24–11; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
Federal Emergency Management
Agency
[Internal Agency Docket No. FEMA–1955–
DR; Docket ID FEMA–2011–0001]
Utah; Amendment No. 1 to Notice of a
Major Disaster Declaration
Federal Emergency
Management Agency, DHS.
ACTION: Notice.
AGENCY:
This notice amends the notice
of a major disaster declaration for the
State of Utah (FEMA–1955–DR), dated
February 11, 2011, and related
determinations.
SUMMARY:
Center for Scientific Review; Notice of
Closed Meeting
DATES:
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
Peggy Miller, Office of Response and
Recovery, Federal Emergency
PO 00000
Frm 00075
Fmt 4703
Sfmt 4703
Effective Date: March 11, 2011.
FOR FURTHER INFORMATION CONTACT:
E:\FR\FM\25MRN1.SGM
25MRN1
]]>Agencies
[Federal Register Volume 76, Number 58 (Friday, March 25, 2011)]
[Notices]
[Pages 16797-16798]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-7137]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Center for Research Resources; Notice of Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Center for Research Resources
Special Emphasis Panel; LOAN REPAYMENT.
Date: April 7, 2011.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Carol Lambert, PhD, Scientific Review Officer,
Office of Review, NCRR, National Institutes of Health, 6701
Democracy Blvd., One Democracy Plaza, Room 1076, MSC 4874, Bethesda,
MD 20892-4874, 301-435-0814, lambert@mail.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing
[[Page 16798]]
limitations imposed by the review and funding cycle.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research; 93.371, Biomedical
Technology; 93.389, Research Infrastructure, 93.306, 93.333; 93.702,
ARRA Related Construction Awards., National Institutes of Health,
HHS)
Dated: March 21, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2011-7137 Filed 3-24-11; 8:45 am]
BILLING CODE 4140-01-P
